Shanghai, China

Tianjing Zhao

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Cocrystal Pharma, Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tianjing Zhao. Retrieved from https://idiyas.com/inventor/tianjing-zhao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Influenza Therapeutics by Tianjing Zhao

Introduction

Tianjing Zhao is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of antiviral therapeutics, particularly in the treatment of influenza. His innovative work has led to the development of a unique formulation that is suitable for administration via inhalation.

Latest Patents

Tianjing Zhao holds 1 patent for his invention titled "Formulations of influenza therapeutics." This patent provides compositions of an antiviral therapeutic designed to effectively treat influenza, showcasing his commitment to advancing medical science.

Career Highlights

Tianjing Zhao is currently employed at Cocrystal Pharma, Inc., where he continues to work on groundbreaking research in antiviral therapies. His expertise and dedication have positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

He collaborates with notable colleagues, including Liang Mao and Irina C Jacobson, to further enhance the development of innovative therapeutic solutions.

Conclusion

Tianjing Zhao's contributions to influenza therapeutics exemplify the impact of innovation in healthcare. His work not only addresses a critical need but also paves the way for future advancements in antiviral treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…